The New Look of Nicotine
Overview of vaping, prevalence of use, toxicology & safety About this event In this presentation, “The New Look of Nicotine Addiction” , participants will receive an overview of vaping 101,…
Smokers and Covid-19 risk: a new CoEHAR study confirms that vaccines are less effective on smokers
According to the researchers from CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, in partnership with the University of Pavia and the University of Milan “Statale”, the analysis of the international studies conducted on the humoral response to Covid-19 vaccines confirmed the negative impact of smoking on antibodies levels induced by vaccine and the rapid lowering of the vaccine-elicited IgG titres over six months
The geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving
The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa
Plos Biology: 9 more excellences from the CoEHAR of the University of Catania
These are the professors: Margherita Ferrante, Antonio Gagliano, Fabio Galvano, Giuseppe Grasso, Sandro La Vignera, Venerando Rapisarda.
Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference
The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.
Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
The CoEHAR smile operation has started: enrolled the first patient of Smile Study
With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).
DIASMOKE: the patient recruitment phase has officially started
CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, has launched a two-year study, the Diasmoke project, to investigate whether vaping or using E-cigarettes reduces the risk of cardiovascular (heart and circulation) disease as compared to normal smoking.
Vaping: necessary clinic and functional indicators to assess tobacco harm reduction and related benefits
Tobacco harm reduction theories and their fundamental principles are questioned worldwide. New indicators specifically designed to establish the harm reduction potential of low risk tobacco products are examined by CoEHAR, with promising results
World No Tobacco Day 2021: CoEHAR organise a seminar on smoking cessation
For the annual World No Tobacco Day 2021, the Center of Excellence for the acceleration of Harm Reduction (CoEHAR), in collaboration with AOU Policlinico “G. Rodolico-S.Marco“ of Catania, and the…
